Senior Investigator, Lady Davis Institute
Guillaume Galbaud du Fort is a consultation-liaison psychiatrist at the McGill University Health Centre, specialized in the psychiatric care of oncology patients and an epidemiologist at the Jewish General Hospital Centre for Clinical Epidemiology and Community Studies, where he is involved in various research projects in the field of epidemiology and pharmaco epidemiology in psychiatry, with his main topic of research being the development and assessment of screening tools for depression in medically ill populations.
Major Research Activities
Azoulay L, Dell’Aniello S, Huiart L, Galbaud du Fort G, Suissa S (2011).Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence. Breast Cancer Research and Treatment, 126(3):695–703.
Béland SG, Tournier M, Galbaud du Fort G, Crott R, Ducruet T, Pariente A, Moride Y (2011). Economical impact of non-persistence with antidepressant treatment in the adult population of Québec: A comparative cost-effectiveness approach. Value in Health, 14(4):492-498.
Nguyen TV, Sockalingam S, Granich A, Chan P, Abbey S, Galbaud du Fort G (2011). Psychosomatic medicine and psychiatry residents: a pan-canadian survey. Psychosomatics, 52(4):354-361.